Several groups have studied RARβ methylation status in NSCLC; but the lack of systemic and quantitative analysis of methylation of RARβ in NSCLC and its relationship with the clinical parameters really hampers the appreciation of mechanism of lung cancer as well as the development of novel tools for diagnosis and treatment of NSCLC patients. This evidence concerns the gene RARB and non-small cell lung carcinoma.